Associated Papers
KIT amplitude-based multiplex droplet digital polymerase chain reaction outperforms direct sequencing for sensitive KIT D816 genotyping in core binding factor acute myeloid leukemia.
Mizuta S et al.
Laboratory Medicine, 2025
Clinical impact of c-KIT and CEBPA mutations in 33 patients with corebinding factor (Non-M3) acute myeloid leukemia.
Mao X et al.
Pediatrics and Neonatology, 2023
Prognostic values of D816V KIT mutation and peri-transplant CBFB-MYH11 MRD monitoring on acute myeloid leukemia with CBFB-MYH11.
Cho BS et al.
Bone Marrow Transplantation, 2021
Prognostic Impacts of D816V KIT Mutation and Peri-Transplant RUNX1-RUNX1T1 MRD Monitoring on Acute Myeloid Leukemia with RUNX1-RUNX1T1.
Cho BS et al.
Cancers, 2021
Different prognostic effects of core-binding factor positive AML with Korean AML registry data.
Shin HJ et al.
Annals of Hematology, 2019
A novel melting curve-based method for detecting c-kit mutations in acute myeloid leukemia.
Lu Q et al.
Oncology Letters, 2014
Hidden mastocytosis in acute myeloid leukemia with t(8;21)(q22;q22).
Johnson RC et al.
American Journal of Clinical Pathology, 2013
Integrative analysis of prognostic factors in Chinese core binding factor leukemia.
Wang D et al.
Biochemical and Biophysical Research Communications, 2012
Complementing mutations in core binding factor leukemias: from mouse models to clinical applications.
Müller AM et al.
Oncogene, 2008
Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia.
Goemans BF et al.
Leukemia, 2005
Mutations in the receptor tyrosine kinase pathway are associated with clinical outcome in patients with acute myeloblastic leukemia harboring t(8;21)(q22;q22).
Nanri T et al.
Leukemia, 2005
Select a paper to view details